AwardedCzechiaGoodsCZK 12,571,000
Selektivní Imunosupresiva - Tofacitinib II.
- Published
- Published 12 December 2024
- Deadline
- Closed 15 January 2025
Overview
The Institute of Clinical and Experimental Medicine procured selective immunosuppressive drug supplies containing tofacitinib (ATC L04AA29) for treating patients with ulcerative colitis according to approved indications. The contract was awarded to PHOENIX lékárenský velkoobchod, s.r.o. for 12,569,771.5 CZK in January 2025.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 12,571,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 12 December 2024
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- CZK 12,569,772
- Award date
- 22 January 2025
- Contract period
- 17 February 2025 → 27 January 2029
- PHOENIX lékárenský velkoobchod, s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
13 February 2025
Contract Notice
12 December 2024
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.